Global Vaccine Combinations Market Growth (Status and Outlook) 2022-2028
- LP 4879822
- 87 Pages
- March 2022
- Pharmaceuticals
The United States Vaccine Combinations market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vaccine Combinations market, reaching US$ million by the year 2028. As for the Europe Vaccine Combinations landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vaccine Combinations players cover Sanofi, Merck, GlaxoSmithKline, and MSD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Combinations market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Two Combinations
Three Combinations
Four Combinations
Six Combinations
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Merck
GlaxoSmithKline
MSD
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Combinations Market Size 2017-2028
2.1.2 Vaccine Combinations Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Vaccine Combinations Segment by Type
2.2.1 Two Combinations
2.2.2 Three Combinations
2.2.3 Four Combinations
2.2.4 Six Combinations
2.3 Vaccine Combinations Market Size by Type
2.3.1 Vaccine Combinations Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Vaccine Combinations Market Size Market Share by Type (2017-2022)
2.4 Vaccine Combinations Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Vaccine Combinations Market Size by Application
2.5.1 Vaccine Combinations Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Vaccine Combinations Market Size Market Share by Application (2017-2022)
3 Vaccine Combinations Market Size by Player
3.1 Vaccine Combinations Market Size Market Share by Players
3.1.1 Global Vaccine Combinations Revenue by Players (2020-2022)
3.1.2 Global Vaccine Combinations Revenue Market Share by Players (2020-2022)
3.2 Global Vaccine Combinations Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vaccine Combinations by Regions
4.1 Vaccine Combinations Market Size by Regions (2017-2022)
4.2 Americas Vaccine Combinations Market Size Growth (2017-2022)
4.3 APAC Vaccine Combinations Market Size Growth (2017-2022)
4.4 Europe Vaccine Combinations Market Size Growth (2017-2022)
4.5 Middle East & Africa Vaccine Combinations Market Size Growth (2017-2022)
5 Americas
5.1 Americas Vaccine Combinations Market Size by Country (2017-2022)
5.2 Americas Vaccine Combinations Market Size by Type (2017-2022)
5.3 Americas Vaccine Combinations Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Combinations Market Size by Region (2017-2022)
6.2 APAC Vaccine Combinations Market Size by Type (2017-2022)
6.3 APAC Vaccine Combinations Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine Combinations by Country (2017-2022)
7.2 Europe Vaccine Combinations Market Size by Type (2017-2022)
7.3 Europe Vaccine Combinations Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Combinations by Region (2017-2022)
8.2 Middle East & Africa Vaccine Combinations Market Size by Type (2017-2022)
8.3 Middle East & Africa Vaccine Combinations Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vaccine Combinations Market Forecast
10.1 Global Vaccine Combinations Forecast by Regions (2023-2028)
10.1.1 Global Vaccine Combinations Forecast by Regions (2023-2028)
10.1.2 Americas Vaccine Combinations Forecast
10.1.3 APAC Vaccine Combinations Forecast
10.1.4 Europe Vaccine Combinations Forecast
10.1.5 Middle East & Africa Vaccine Combinations Forecast
10.2 Americas Vaccine Combinations Forecast by Country (2023-2028)
10.2.1 United States Vaccine Combinations Market Forecast
10.2.2 Canada Vaccine Combinations Market Forecast
10.2.3 Mexico Vaccine Combinations Market Forecast
10.2.4 Brazil Vaccine Combinations Market Forecast
10.3 APAC Vaccine Combinations Forecast by Region (2023-2028)
10.3.1 China Vaccine Combinations Market Forecast
10.3.2 Japan Vaccine Combinations Market Forecast
10.3.3 Korea Vaccine Combinations Market Forecast
10.3.4 Southeast Asia Vaccine Combinations Market Forecast
10.3.5 India Vaccine Combinations Market Forecast
10.3.6 Australia Vaccine Combinations Market Forecast
10.4 Europe Vaccine Combinations Forecast by Country (2023-2028)
10.4.1 Germany Vaccine Combinations Market Forecast
10.4.2 France Vaccine Combinations Market Forecast
10.4.3 UK Vaccine Combinations Market Forecast
10.4.4 Italy Vaccine Combinations Market Forecast
10.4.5 Russia Vaccine Combinations Market Forecast
10.5 Middle East & Africa Vaccine Combinations Forecast by Region (2023-2028)
10.5.1 Egypt Vaccine Combinations Market Forecast
10.5.2 South Africa Vaccine Combinations Market Forecast
10.5.3 Israel Vaccine Combinations Market Forecast
10.5.4 Turkey Vaccine Combinations Market Forecast
10.5.5 GCC Countries Vaccine Combinations Market Forecast
10.6 Global Vaccine Combinations Forecast by Type (2023-2028)
10.7 Global Vaccine Combinations Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Vaccine Combinations Product Offered
11.1.3 Sanofi Vaccine Combinations Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Vaccine Combinations Product Offered
11.2.3 Merck Vaccine Combinations Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Vaccine Combinations Product Offered
11.3.3 GlaxoSmithKline Vaccine Combinations Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 MSD
11.4.1 MSD Company Information
11.4.2 MSD Vaccine Combinations Product Offered
11.4.3 MSD Vaccine Combinations Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 MSD Main Business Overview
11.4.5 MSD Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Vaccine Combinations Product Offered
11.5.3 Pfizer Vaccine Combinations Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
12 Research Findings and Conclusion
Table 1. Vaccine Combinations Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Two Combinations
Table 3. Major Players of Three Combinations
Table 4. Major Players of Four Combinations
Table 5. Major Players of Six Combinations
Table 6. Vaccine Combinations Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Vaccine Combinations Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Vaccine Combinations Market Size Market Share by Type (2017-2022)
Table 9. Vaccine Combinations Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Vaccine Combinations Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Vaccine Combinations Market Size Market Share by Application (2017-2022)
Table 12. Global Vaccine Combinations Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Vaccine Combinations Revenue Market Share by Player (2020-2022)
Table 14. Vaccine Combinations Key Players Head office and Products Offered
Table 15. Vaccine Combinations Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaccine Combinations Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Vaccine Combinations Market Size Market Share by Regions (2017-2022)
Table 20. Americas Vaccine Combinations Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Vaccine Combinations Market Size Market Share by Country (2017-2022)
Table 22. Americas Vaccine Combinations Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Vaccine Combinations Market Size Market Share by Type (2017-2022)
Table 24. Americas Vaccine Combinations Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Vaccine Combinations Market Size Market Share by Application (2017-2022)
Table 26. APAC Vaccine Combinations Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Vaccine Combinations Market Size Market Share by Region (2017-2022)
Table 28. APAC Vaccine Combinations Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Vaccine Combinations Market Size Market Share by Type (2017-2022)
Table 30. APAC Vaccine Combinations Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Vaccine Combinations Market Size Market Share by Application (2017-2022)
Table 32. Europe Vaccine Combinations Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Vaccine Combinations Market Size Market Share by Country (2017-2022)
Table 34. Europe Vaccine Combinations Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Vaccine Combinations Market Size Market Share by Type (2017-2022)
Table 36. Europe Vaccine Combinations Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Vaccine Combinations Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Vaccine Combinations Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Vaccine Combinations Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Vaccine Combinations Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Vaccine Combinations Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Vaccine Combinations Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Vaccine Combinations Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Vaccine Combinations
Table 45. Key Market Challenges & Risks of Vaccine Combinations
Table 46. Key Industry Trends of Vaccine Combinations
Table 47. Global Vaccine Combinations Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Vaccine Combinations Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Vaccine Combinations Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Vaccine Combinations Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Vaccine Combinations Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Vaccine Combinations Market Size Market Share Forecast by Application (2023-2028)
Table 53. Sanofi Details, Company Type, Vaccine Combinations Area Served and Its Competitors
Table 54. Sanofi Vaccine Combinations Product Offered
Table 55. Sanofi Vaccine Combinations Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Merck Details, Company Type, Vaccine Combinations Area Served and Its Competitors
Table 59. Merck Vaccine Combinations Product Offered
Table 60. Merck Main Business
Table 61. Merck Vaccine Combinations Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Merck Latest Developments
Table 63. GlaxoSmithKline Details, Company Type, Vaccine Combinations Area Served and Its Competitors
Table 64. GlaxoSmithKline Vaccine Combinations Product Offered
Table 65. GlaxoSmithKline Main Business
Table 66. GlaxoSmithKline Vaccine Combinations Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. GlaxoSmithKline Latest Developments
Table 68. MSD Details, Company Type, Vaccine Combinations Area Served and Its Competitors
Table 69. MSD Vaccine Combinations Product Offered
Table 70. MSD Main Business
Table 71. MSD Vaccine Combinations Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. MSD Latest Developments
Table 73. Pfizer Details, Company Type, Vaccine Combinations Area Served and Its Competitors
Table 74. Pfizer Vaccine Combinations Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Vaccine Combinations Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Pfizer Latest Developments
List of Figures
Figure 1. Vaccine Combinations Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Combinations Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Vaccine Combinations Market Size Market Share by Type in 2021
Figure 7. Vaccine Combinations in Adults
Figure 8. Global Vaccine Combinations Market: Adults (2017-2022) & ($ Millions)
Figure 9. Vaccine Combinations in Children
Figure 10. Global Vaccine Combinations Market: Children (2017-2022) & ($ Millions)
Figure 11. Global Vaccine Combinations Market Size Market Share by Application in 2021
Figure 12. Global Vaccine Combinations Revenue Market Share by Player in 2021
Figure 13. Global Vaccine Combinations Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Vaccine Combinations Market Size 2017-2022 ($ Millions)
Figure 15. APAC Vaccine Combinations Market Size 2017-2022 ($ Millions)
Figure 16. Europe Vaccine Combinations Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Vaccine Combinations Market Size 2017-2022 ($ Millions)
Figure 18. Americas Vaccine Combinations Value Market Share by Country in 2021
Figure 19. Americas Vaccine Combinations Consumption Market Share by Type in 2021
Figure 20. Americas Vaccine Combinations Market Size Market Share by Application in 2021
Figure 21. United States Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Vaccine Combinations Market Size Market Share by Region in 2021
Figure 26. APAC Vaccine Combinations Market Size Market Share by Application in 2021
Figure 27. China Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Vaccine Combinations Market Size Market Share by Country in 2021
Figure 34. Europe Vaccine Combinations Market Size Market Share by Type in 2021
Figure 35. Europe Vaccine Combinations Market Size Market Share by Application in 2021
Figure 36. Germany Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Vaccine Combinations Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Vaccine Combinations Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Vaccine Combinations Market Size Market Share by Application in 2021
Figure 44. Egypt Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Vaccine Combinations Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 50. APAC Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 51. Europe Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 53. United States Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 54. Canada Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 57. China Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 58. Japan Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 59. Korea Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 61. India Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 62. Australia Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 63. Germany Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 64. France Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 65. UK Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 66. Italy Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 67. Russia Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 68. Spain Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 71. Israel Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Vaccine Combinations Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Vaccine Combinations Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
